Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040308A2 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
05/15/2003WO2003040307A2 Heteromultimeric tnf ligand family members
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003040178A1 Method for identifying or screening anti-viral agents
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040169A2 Human monoclonal antibodies to dendritic cells
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003039595A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
05/15/2003WO2003039594A2 Antigen presenting vesicles
05/15/2003WO2003039592A2 Cellular vaccines comprising adjuvants
05/15/2003WO2003039591A2 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell
05/15/2003WO2003039588A1 Pharmaceutical composition comprising factor vii polypeptides and tissue plasminogen inhibitors
05/15/2003WO2003039587A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors
05/15/2003WO2003039585A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039491A2 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003WO2003039486A2 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
05/15/2003WO2003039485A2 Stable liquid pharmaceutical formulation of igg antibodies
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor
05/15/2003WO2003039470A2 Polyvalent immunogen of hiv
05/15/2003WO2003039466A2 Method of treating estrogen responsive breast cancer
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039404A2 Methods for treating ocular neovascular diseases
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2003039232A2 Endothelial cell derived hemotopoietic growth factor
05/15/2003WO2003039225A2 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003WO2003011336A3 Liposomes prepared from the extractable lipids from a mycobacterium
05/15/2003WO2002100836A3 Compounds, compositions and methods for modulating beta-amyloid production
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002094316A3 Method of preparing aluminium-hydroxide gel
05/15/2003WO2002059156A3 Therapeutic compounds structurally-linked to bacterial polypeptides
05/15/2003WO2002056027A3 Regulation of neutral development by daedalos
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003US20030092903 Nucleotide sequences coing polypeptide for use in the treatment, diagnosis and prevention of lymes's disease
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092894 Conjugated antigen for use as tool in the treatment of cancer
05/15/2003US20030092892 Crosslinking, agglutination, purification
05/15/2003US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092665 Methods and compositions for administering DNA to mucosal surfaces
05/15/2003US20030092663 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
05/15/2003US20030092631 IGF antagonist peptides
05/15/2003US20030092607 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092177 Preparing preferential cells from mononucler cells in culture; obtain monocytes, incubate with interferon, recover preferental cells
05/15/2003US20030092174 Tissues or organs for use in xenotransplantation
05/15/2003US20030092145 Viricidal agent for use in the treatment and prevention of viral diseases
05/15/2003US20030092118 Hyaluronan synthase genes and expression thereof in bacillus hosts
05/15/2003US20030092087 Ehrlichia disulfide bond formation proteins and uses thereof
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030091987 Materials and methods for detecting, preventing, and treating retroviral infection
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091649 ICAM-1 formulation having controlled-size microparticles
05/15/2003US20030091637 Drug core with polymeric overcoating
05/15/2003US20030091599 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
05/15/2003US20030091597 Genetic engineering; screening for tuberculosis
05/15/2003US20030091595 West nile vaccine
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091593 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
05/15/2003US20030091591 Parasiticides; veterinary medicine
05/15/2003US20030091588 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
05/15/2003US20030091586 Fish immunoglobulin
05/15/2003US20030091585 Vaccine composition containing a promoter peptide
05/15/2003US20030091583 Use of mia in immunotheraphy
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091581 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
05/15/2003US20030091580 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/15/2003US20030091579 Reducing gonad circulation steroid in cattle, swine
05/15/2003US20030091578 Multiple sclerosis; rheumatic diseases; vaccine
05/15/2003US20030091577 Streptococcus pneumoniae proteins and nucleic acid molecules
05/15/2003US20030091575 Activation immunology response; administering fusion protein
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091565 Binding polypeptides and methods based thereon
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091560 Composition for Pharmaceutical and Cosmetic Products
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091548 Gene therapy for the prevention of autoimmune disease
05/15/2003US20030091541 Method of inducing immunotolerance in an organ transplantation recipient
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030091506 Methods of using 22417, a novel human aminoprotease family member
05/15/2003CA2472055A1 Improved mucosal vaccines and methods for using the same
1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 1823